ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,220.08
0.12%
Dow Jones
39,486.63
0.25%
US Dollar vs MXN
16.7875
-0.04%
Brent Oil
82.645
-1.55%
Bitcoin
60,637.96
-3.81%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Sanofi (SNY)

  7. Sanofi (SNY) Noticias

SNY Sanofi

49.045
0.355 (0.73%)
Última actualización: 13:45:57
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Sanofi SNY NASDAQ Certificado de Depósito
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.355 0.73% 49.045 13:45:57
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
48.80 48.70 49.15 48.69
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
10/5/202407:02IHMARKETNEWSNovavax Surges 57% Post $1.4 Billion Sanofi Deal; Apple..
10/5/202401:00PRNUSNovavax and Sanofi Announce Co-exclusive Licensing Agreement..
25/4/202406:52IHMARKETNEWSSouthwest Shares Tumble 9.6% Post $231 Million 1Q Loss,..
19/4/202406:31IHMARKETNEWSParamount’s Shares Surge Following Sony and Apollo’s Joint..
23/2/202413:02EDGAR2Form IRANNOTICE - Notice of disclosure filed pursuant to..
23/2/202410:15EDGAR2Form 20-F - Annual and transition report of foreign private..
15/2/202411:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
14/2/202414:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
25/1/202413:29GLOBEDupixent® (dupilumab) FDA Approved as First and Only..
23/1/202406:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23/1/202405:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
23/1/202404:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
23/1/202400:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
17/1/202412:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/1/202401:14DJNSanofi Names Brian Foard Head of Specialty-Care Unit
27/12/202310:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202301:25DJNSanofi Ends Drug Program After Late-Stage Trial in Lung..
19/12/202306:28DJNInnate Pharma Shares Rise after Sanofi Exercises Licensing..
12/12/202304:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
11/12/202316:18DJNSanofi Terminates Agreement with Maze Therapeutics Following..
11/12/202300:50DJNSanofi Sees Improvement in Trial Results of Cancer Drug..
07/12/202301:34DJNSanofi Myeloma Drug Sarclisa Met Primary Goal in Late-Stage..
07/12/202301:20DJNSanofi Sees Annual Sales From New Pharma Assets Above $10.8..
06/12/202307:20DJNTrending: Merck's Multiple Sclerosis Drug Misses..
06/12/202304:14DJNMerck Shares Slump After Multiple Sclerosis Drug Fails in..
30/11/202308:23DJNTeva Closes Collaboration Deal With Sanofi on IBD Treatment
30/11/202307:30BWTeva Completes Closing of Exclusive Collaboration Deal to..
27/11/202309:31DJNTrending: Sanofi's Notus Trial Meets Primary Endpoint
27/11/202301:40DJNSanofi Says Notus Phase 3 Trial of Dupixent Met Primary..
27/11/202300:30GLOBEDupixent® (dupilumab) Significantly Reduced COPD..
07/11/202315:01APSOrphan Drugs Worth $64 Billion by 2028 and This Micro Cap..
07/11/202307:56DJNSanofi Under Preliminary Probe in France Over Possible..
07/11/202306:10IHMARKETNEWSTuesday’s Wall Street Highlights: WeWork, UBS, Sanofi,..
06/11/202306:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
02/11/202311:15PRNUSSanofi honors 10 advocacy organizations promoting health..
01/11/202307:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202306:00PRNUSSanofi launches "The 1 Pledge" movement to drive early..
30/10/202307:14DJNMeiraGTx Gets $30 Million Investment From Sanofi
27/10/202311:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202310:47DJNSanofi Down Over 19%, on Pace for Record Percent Decrease --..
27/10/202310:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/10/202306:10IHMARKETNEWSFriday’s Wall Street Highlights: Enphase Energy, GM, Intel,..
27/10/202303:43DJNSanofi Shares Tumble After Warning of Profit Hit From..
27/10/202301:54DJNSanofi Backs Guidance After Earnings, Sales Miss Views
27/10/202301:35DJNSanofi Plans to Split Consumer-Healthcare, Pharma Businesses..
27/10/202301:07DJNSanofi Plans to Spin Off Consumer-Healthcare Business
26/10/202306:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/10/202313:59GLOBEDupixent® (dupilumab) Phase 3 Results Show Sustained..
20/10/202313:31EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
18/10/202304:40DJNSanofi Says Drug Shows Potential to Slow Diabetes in..

Su Consulta Reciente

NASDAQ
SNY
Sanofi
NYSE
TCO
Taubman Centers
NASDAQ
ASBP
Asb Financial
LSE
100I
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados